 CAMBRIDGE, Mass., Sept. 27, 2022 GLOBE NEWSWIRE -- Voyager Therapeutics, Inc. Nasdaq: VYGR, a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus AAV capsids, today announced that management will participate in the following investor conferences: 